Jack Higgins - 02 Apr 2026 Form 4 Insider Report for Immunome Inc. (IMNM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Apr 2026, 19:48:14 UTC
Prior SEC filing
01 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sandra Stoneman, Attorney-in-Fact

Key filing fact

Jack Higgins filed Form 4 for Immunome Inc. (IMNM) on 03 Apr 2026.

Key facts

  • This page summarizes Jack Higgins's Form 4 filing for Immunome Inc. (IMNM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2026, 19:48.

Change

  • Previous filing in this sequence was filed on 01 Apr 2026.
  • Current net transaction value: -$204,238.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001993684 Primary reporting owner

Higgins Jack

Relationship
Chief Scientific Officer
Address
C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Signature date
03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMNM transaction

Common Stock

Sale

Transaction value
$204,238
Shares
-9,438
Change %
-30%
Price
$21.64
Shares after
22,000
Date
02 Apr 2026
Ownership
Direct
Footnotes
F1
IMNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
02 Apr 2026
Ownership
As Custodian for Child 1
Footnotes
F2
IMNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
02 Apr 2026
Ownership
As Custodian for Child 2
Footnotes
F2
IMNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
02 Apr 2026
Ownership
As Custodian for Child 3
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

Footnote F2

The Reporting Person serves as a custodian of a custodial account for his child pursuant to the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .